HighTower Advisors’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,333
Closed -$7K 3767
2023
Q1
$7K Hold
1,333
﹤0.01% 3217
2022
Q4
$7K Hold
1,333
﹤0.01% 3195
2022
Q3
$7K Hold
1,333
﹤0.01% 3041
2022
Q2
$12K Hold
1,333
﹤0.01% 3053
2022
Q1
$21K Sell
1,333
-44
-3% -$763 ﹤0.01% 3164
2021
Q4
$36K Buy
1,377
+44
+3% +$1.67K ﹤0.01% 3054
2021
Q3
$65K Sell
1,333
-180
-12% -$11.1K ﹤0.01% 2913
2021
Q2
$127K Hold
1,513
﹤0.01% 2763
2021
Q1
$153K Buy
1,513
+40
+3% +$4.4K ﹤0.01% 2670
2020
Q4
$148K Buy
1,473
+140
+11% +$9.35K ﹤0.01% 2276
2020
Q3
$62K Hold
1,333
﹤0.01% 2290
2020
Q2
$77K Buy
+1,333
New +$89K ﹤0.01% 2159

Other funds holding AWH

HighTower Advisors's AWH Position: Q2 2023 in Review

HighTower Advisors sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2023, closing a stake of 1,333 shares — an estimated $7K sold.

HighTower Advisors first reported a position in AWH in Q2 2020 and held it in 12 quarters. The position peaked at $153K in Q1 2021. 22 funds tracked by Wall St. Rank hold AWH as of Q2 2023.

  • HighTower Advisors reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • HighTower Advisors sold 1,333 Aspira Women's Health Inc. Common Stock shares in Q2 2023, an estimated $7K.
  • HighTower Advisors first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • HighTower Advisors's Aspira Women's Health Inc. Common Stock position peaked at $153K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2023.

Based on HighTower Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.